Literature DB >> 14699030

Composite pelvic exenteration: is it worthwhile?

Marvin J Lopez1, Pedro Luna-Pérez.   

Abstract

BACKGROUND: In locally advanced pelvic cancer, tumor fixation to the bony pelvis is regarded as unresectable and often inoperable. Few data exist regarding the futility or utility of pelvic exenteration with en bloc resection of involved portions of the bony pelvis.
METHODS: Thirty-four of 625 patients undergoing radical pelvic procedures had an en bloc resection of pelvic organs with portions of the bony pelvis. There were 19 female and 15 male patients, and the median age was 59 years. Primary neoplasms included 19 rectal, 6 cervicouterine, 4 anal, 3 vaginal, 1 sarcoma, and 1 penile. All but three patients underwent preoperative pelvic irradiation. Pelvic exenterations were posterior in 7 patients, anterior in 3, supralevator in 3, and total in 21 patients. Pelvic bony resections included portions of the sacrum-coccyx in 18 patients, ischium in 5, pubic symphysis in 4, and ischial pubic rami in 4, and hemipelvectomy was performed in 3.
RESULTS: Surgical morbidity occurred in 67.6% (23) of 24 patients. Median follow-up was 37 months. Pelvic or perineal tumor recurrence was concurrent with distant metastases in 9 patients (26.4%); 6 (17.6%) had only distant relapse, and 2 (5.8%) died with local recurrence alone. Overall cancer-related mortality rate was 50%. Five-year overall and cancer-specific survival rates were 44% and 52%, respectively.
CONCLUSIONS: Substantial survival can be accomplished for patients whose tumors are fixed to limited portions of the bony pelvis. These procedures are still associated with substantial morbidity, but operative mortality is infrequent.

Entities:  

Mesh:

Year:  2004        PMID: 14699030     DOI: 10.1007/BF02524342

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  En Bloc Resection with Partial Sacrectomy Helps to Achieve R0 Resection in Locally Advanced Rectal Cancer, Experience from a Tertiary Cancer Center.

Authors:  Nizamudheen M Pareekutty; Satheesan Balasubramanian; Sachin Kadam; Dipin Jayaprakash; Basavaraj Ankalkoti; Sangeetha Nayanar; Geetha Muttath; Bindu Anilkumar
Journal:  Indian J Surg Oncol       Date:  2019-01-09

2.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

3.  Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.

Authors:  Dariusz Wydra; Janusz Emerich; Sambor Sawicki; Katarzyna Ciach; Andrzej Marciniak
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

4.  Comparison of immediate surgical outcomes between posterior pelvic exenteration and standard resection for primary rectal cancer: a matched case-control study.

Authors:  Varut Lohsiriwat; Darin Lohsiriwat
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

5.  Extended abdominoperineal resection in women: the Barbadian experience.

Authors:  Andrew P Zbar; Radhakanth K Shenoy; Antonio Chiappa
Journal:  Int Semin Surg Oncol       Date:  2007-01-10

Review 6.  Locally advanced rectal cancer: management challenges.

Authors:  R F Kokelaar; M D Evans; M Davies; D A Harris; J Beynon
Journal:  Onco Targets Ther       Date:  2016-10-13       Impact factor: 4.147

7.  The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction.

Authors:  Racheal Louise Johnson; Alexandros Laios; David Jackson; David Nugent; Nicolas Michel Orsi; Georgios Theophilou; Amudha Thangavelu; Diederick de Jong
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.